Objectives To evaluate the temporal association between the diagnosis of neoplasia and sarcoidosis in a large cohort of Spanish patients with sarcoidosis.
Methods In January 2016, the Autoimmune Diseases Study Group (GEAS-SEMI) created a national registry (SARCOGEAS) of patients with sarcoidosis. Sarcoidosis was diagnosed with the criteria proposed by the ATS/ERS/WASOG 1999 statement, and extrathoracic disease by the 2014 WASOG instrument. Diagnosis of neoplasia was recorded before and after the diagnosis of sarcoidosis.
Results The cohort included 1082 patients (82% biopsy-proven, 618 women, mean age 47yrs). Association with neoplasia was detected in 135 (13%) patients who developed 140 neoplasms (110 solid and 30 hematological neoplasia). The neoplasia more frequently reported were breast (n=18), lymphoma (n=16), non-melanoma skin (n=15) and colon (n=15). Association with neoplasia was more frequent in patients born in Spain (97% vs 86%, p<0.001, OR 4.06), older patients (55 vs 46yrs, p<0.001, OR 1.03) and those with bone marrow involvement (14% vs 4%, p<0.001, OR 3.64). Patients in whom cancer preceded the diagnosis of sarcoidosis had a higher frequency of sarcoidosis diagnosed incidentally (20% vs 4%, p=0.011) and a lower frequency of ocular sarcoidosis (3% vs 16%, p=0.016). Patients with associated hematological neoplasia had a higher frequency of ENT (13% vs 1%, p=0.009) and bone marrow (33% vs 9%, p=0.002) involvements in comparison with patients with associated solid neoplasia.
Conclusions Association between sarcoidosis and cancer was found in 13% of patients (80% solid and 20% hematologic malignancies). Elderly patients and those born in Spain were at high risk of having associated cancer. Asymptomatic sarcoidosis was more frequently observed in those patients with a previous history of neoplasia, while the association with hematological neoplasms was linked to a higher frequency of sarcoidosis involving ENT and bone marrow.
Disclosure of Interest None declared
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.